VEGFA and renal cell carcinoma: Over the past few decades, benefiting from the development of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors and immune checkpoint inhibitors (ICIs), immunotherapy has been widely used in the treatment of RCC (18–20).